AL EMB IC PH R CU TS LI D Ale,-r'lbic~ 1co:, CIN ... · ' AL EMB IC PH R CU TS LI D Ale,-r'lbic~...
1
/. 1 , ' ALEMBIC PHARMACEUTICALS LIMITED Al e,-r'l bi c ~ Regd. Office: Alembic Road, Vadodara 390 003 CIN: L24230GJ2010PLC061123 · - - . - Touching Lives over 1c o:, Ph: 0265~2280550 Fax: 0265-2282506 years Email: apl.investors@alembic.co.in . , Website: .www.alembicpharmaceuticals.com Extract of Statement of Consolidated Audited Financial Results for the quarter and year ended 31st March, 2019 (~ in Crs. except per share data) ; · Consolidated Particulars Quarter Ended Year Ended Quarter Ended . . 31.03.2019 31.03.2019 31.03.2018 Total Income from Operations 926.95 3,934.68 853.31 Net Profit for the period (before Tax, 146.38 749.32 140.96 Exceptional and/ or Extraordinary ' items) Net Profit for the period before tax 146.38 749.32 140.96 (after Exceptional and/ or .. . . . Extraordinary items) Net Profit for the period after tax 124.00 584.37 93.79 (after Exceptional and/ or Extraordinary items) - Total Comprehensive Income for 122.25 589.12 92.93 the period Equity Share Capital 37.70 37.70 37.70 Reserves (excluding Revaluation . 2,681.12 - Reserve) as shown in the Audited Balance Sheet of previous year . Earning Per Share (of Rs. 2/- each) 6.58 ·,' 31.00 4.98 Basic & Diluted" " ' Research and Development Expenses -119.74 498.16 121.12 " Notes: - Quarter Ended Year Ended Quarter Ended 1. Standalone details 31.03.2019 31.03.2019 31.03.2018 Income from Operations 848.70 3,660.27 838.22 Profit Before Tax . 122,08 764.63 ~ 178.51 . - Profit After Tax 107.66 611.21 144.19 Research and Development Expenses . , 121.41. 462.26 110.90 ~ 2. The above is an extract of the detailed format of quarter and year ended audited financial results filed with the Stock Exchanges under Regulation. 33 of the SEBI (Listing Obligations and Disclosure · Requirements) Regulations, 2015. The full format of the quarter and year ended audited financial results are available on the Company's website at www.alembicpharmaceuticals.com and the Stock Exchange's website atwww.nseindia.com and www._bseindia.com For Alembic Pharmaceuticals Li mited V Sd/- Place: Vadodara Chirayu Amin Date: 8th May, 2019 I• Chairman and CEO lo.. .) ~-
Transcript of AL EMB IC PH R CU TS LI D Ale,-r'lbic~ 1co:, CIN ... · ' AL EMB IC PH R CU TS LI D Ale,-r'lbic~...
/.
1 ,
' ALEMBIC PHARMACEUTICALS LIMITED
Ale,-r'lbic~ Regd. Office: Alembic Road, Vadodara 390 003 CIN: L24230GJ2010PLC061123
· --. - Touching Lives over 1co:, Ph: 0265~2280550 Fax: 0265-2282506 years Email: [email protected] .
, Website: .www.alembicpharmaceuticals.com
Extract of Statement of Consolidated Audited Financial Results for the quarter and year ended 31st March, 2019
(~ in Crs. except per share data)
; · Consolidated
Particulars Quarter Ended Year Ended Quarter Ended . .
31.03.2019 31.03.2019 31.03.2018 Total Income from Operations 926.95 3,934.68 853.31 Net Profit for the period (before Tax, 146.38 749.32 140.96 Exceptional and/ or Extraordinary ' items) Net Profit for the period before tax 146.38 749.32 140.96 (after Exceptional and/ or .. . . . Extraordinary items) Net Profit for the period after tax 124.00 584.37 93.79 (after Exceptional and/ or Extraordinary items) - Total Comprehensive Income for 122.25 589.12 92.93 the period Equity Share Capital 37.70 37.70 37.70
Reserves (excluding Revaluation . 2,681.12 - Reserve) as shown in the Audited Balance Sheet of previous year . Earning Per Share (of Rs. 2/- each) 6.58 ·,' 31.00 4.98 Basic & Diluted" "
' Research and Development Expenses -119.74 498.16 121.12
" Notes: - Quarter Ended Year Ended Quarter Ended 1. Standalone details 31.03.2019 31.03.2019 31.03.2018
Income from Operations 848.70 3,660.27 838.22
Profit Before Tax . 122,08 764.63 ~ 178.51 .
- Profit After Tax 107.66 611.21 144.19
Research and Development Expenses . ,
121.41. 462.26 110.90 ~
2. The above is an extract of the detailed format of quarter and year ended audited financial results filed with the Stock Exchanges under Regulation. 33 of the SEBI (Listing Obligations and Disclosure · Requirements) Regulations, 2015. The full format of the quarter and year ended audited financial results are available on the Company's website at www.alembicpharmaceuticals.com and the Stock Exchange's website atwww.nseindia.com and www._bseindia.com
For Alembic Pharmaceuticals Limited V
Sd/- Place: Vadodara Chirayu Amin Date: 8th May, 2019 I• Chairman and CEO
lo.. .)
~-
![EMB-RasPI-130x-Cape Datasheet · Introduction 1 Introduction The EMB-RasPI-130x-Cape is an extension board for both EMB-LR1301-mPCIe [1] and EMB-LR1308-mPCIe, specially designed for](https://static.fdocuments.in/doc/165x107/5f20a68c09341421ba2e5dc3/emb-raspi-130x-cape-introduction-1-introduction-the-emb-raspi-130x-cape-is-an-extension.jpg)
